Abstract
3709 Background: UFT/LV is an orally available regimen with proven activity in MCRC pts. Two randomized phase III trials (J.Y. Douillard et al., JCO 2002; J. Carmichael et al, JCO 2002) showed equi...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
